-transparent.png){kind=logo}
Selective muscarinic antagonists were used in an attempt to characterize the muscarinic autoreceptor modulating the release of acetylcholine in the striatum of the rat. In vivo microdialysis was applied to infuse atropine, 4-DAMP (4-diphenylacetoxy-N-methylpiperidine), pirenzepine or AF-DX 116 (11-[[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5, 11-dihydro[2,3-b][1,4]benzodiazepine-6-one), leading to a dose-dependent increase in the overflow of acetylcholine, the order of potency being: atropine greater than 4-DAMP greater than pirenzepine greater than AF-DX 116. We conclude from these data that the muscarinic receptor modulating release in the striatum is of the M3 type.
P De Boer, and
B H Westerink, and
H Rollema, and
J Zaagsma, and
A S Horn
April 1980,
Acta physiologica Scandinavica,
P De Boer, and
B H Westerink, and
H Rollema, and
J Zaagsma, and
A S Horn
November 1983,
British journal of pharmacology,
P De Boer, and
B H Westerink, and
H Rollema, and
J Zaagsma, and
A S Horn
November 1997,
The Journal of pharmacology and experimental therapeutics,
P De Boer, and
B H Westerink, and
H Rollema, and
J Zaagsma, and
A S Horn
April 2018,
Journal of molecular neuroscience : MN,
P De Boer, and
B H Westerink, and
H Rollema, and
J Zaagsma, and
A S Horn
June 1998,
The EMBO journal,
P De Boer, and
B H Westerink, and
H Rollema, and
J Zaagsma, and
A S Horn
June 1998,
Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi,
P De Boer, and
B H Westerink, and
H Rollema, and
J Zaagsma, and
A S Horn
January 1997,
Archives of medical research,
P De Boer, and
B H Westerink, and
H Rollema, and
J Zaagsma, and
A S Horn
January 1993,
Naunyn-Schmiedeberg's archives of pharmacology,
P De Boer, and
B H Westerink, and
H Rollema, and
J Zaagsma, and
A S Horn
July 1989,
Brain research,
P De Boer, and
B H Westerink, and
H Rollema, and
J Zaagsma, and
A S Horn
August 1999,
British journal of pharmacology,
